About

Viventia Biotech Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Our lead product candidate Proxinium™ is in multiple clinical studies for the treatment of head and neck cancer. Vicinium™ is currently in an on-going clinical study for the treatment of bladder cancer.

Products & services in Etobicoke

Lead product Monoclonal antibody Product design Product designer

Similar companies nearby

Jay Leatherkraft Ltd. 1.0 mi Report cover 219 Norseman Street, Toronto
Dufferin Gate Productions Inc 1.0 mi Lead product 20 Butterick Rd, Etobicoke
Visioneering Corporation 6.1 mi 3d printing 35 Oak St, Toronto
Hudco Electric Supply Ltd. 11.2 mi Wire cable 2901 Steeles Ave W. Unit 17, Toronto
Engineered Foam Products Canada 11.5 mi Product design 111B Snidercroft Rd, Concord